The MarketWatch News Department was not involved in the creation of this content.
Sep 22, 2020 (PRNews Times via COMTEX) — This outbreak of COVID-19 is expected to have a favorable impact on the global IoT in cloud platform market growth in 2020 and is expected to continue its trend in the coming years. During this pandemic period, there are strong signs that several technologies will witness an increased adopting rate in the recent months due to people converted digitally minded and they are adopting IoT technologies while work from home. Also, government bodies are using drone which are mounted with IoT cloud systems for public surveillance to monitor red zones and the wearing masks. Moreover, growing implementation of IoT systems in the healthcare sector to manage patient care including the remote monitoring of in-home patients who are self-quarantined and many other patients like chronic conditions and diabetes. These factors … Read More
Medical Oxygen Concentrators Market Size, Trends and Growth Analysis by Product (Portable Oxygen Concentrators and Stationary Oxygen Concentrators), Technology (Continuous Flow, Pulse Dose), Indication (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea), End User and Region – Forecast till 2024
Medical Oxygen Concentrators Market Landscape
Global Medical Oxygen Concentrators Market stocks have outpaced other rivals since the Coronavirus-driven market selloff bottomed out in March, reflecting the advantages of strong exports globally. Market Research Future accumulated some essential facts on the medical oxygen concentrators market had published a report stating that 7.8% is the CAGR will be the future pace of growth. At this pace, the market is probable to outdo revenue of USD 1,755.8 million gains in the year 2018. The new revenue is expected to gain in the years 2019 to 2024 (forecasted period).
The global medical oxygen concentrators market might witness an upsurge owing to the spread of COVID-19.
The suspension of fertility treatments due to the COVID-19 pandemic has had a variety of psychological impacts on women whose treatments were cancelled, but there are several protective factors that can be fostered to help in the future, according to a new study by Jennifer Gordon and Ashley Balsom of University of Regina, Canada, published 18 September in the open-access journal PLOS ONE.
One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require many in-person appointments to complete. On March 17, 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to immediately and indefinitely suspend all in-person fertility treatments in the United States and Canada due to COVID-19.
In the new study, researchers used online social media advertising to recruit 92 women from Canada and the U.S.
Proposition 14-2020 provides $5.5B in total to continue stem cell research including $1.5B for the support of research and development of treatments toward neurological disorders.
LOS ANGELES, Sept. 16, 2020 /PRNewswire/ — Brain Mapping Foundation (BMF) and Society for Brain Mapping and Therapeutics (SBMT) have been on the forefront of combatting COVID-19 with their enormous network of scientists, physicians, and engineers worldwide. BMF and SBMT formed a COVID-19 global taskforce in February of 2020 and by the first week of March they were connected to 5 different global taskforces in Asia, South America, North America, Middle East and India in real time. “Our taskforce coordinated efforts with our global membership and collaborators to rapidly advance our understanding of COVID-19,” said Vicky Yamamoto, Ph.D., Executive Director of SBMT, Co-Chair of COVID-19 Taskforce and Cancer Scientist, USC-Keck School of Medicine, Department of Otolaryngology/Head and Neck Surgery
Anticipating the coronavirus pandemic that smashed into New York City would crash over his suburban New Jersey community, John Bonanni, a county administrator, believed he’d prepared for the worst. But in early spring, as infections surged and hospital bedspace and ventilators ran short, Bonanni worried the worst might have been an underestimate.
Half a continent away, as Wyoming’s ski season wound down, Jodie Pond’s plan to fight the oncoming contagion ramped up. The health director for a county that includes Jackson Hole, an international tourist destination, Pond and her colleagues decided the area must go on lockdown, even if resort and business owners didn’t like it.
Meanwhile, in the Centennial State, Colorado communities were emerging as coronavirus hot zones, with Denver an epicenter. And as infections mounted, a patchwork of responses led to uneven results in fighting COVID-19.
For example, counties that perform better in U.S. News’ third-annual assessment of
Intolerances to chemicals, foods and drugs impact 8%-33% of individuals, studies suggest, yet few people are screened for it at their doctors’ offices.
To address this and increase awareness of chemical intolerance, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) developed and validated a three-question, yes-or-no survey that primary care providers, allergists, dermatologists and other specialists can incorporate into patient visits. The survey, called the Brief Environmental Exposure and Sensitivity Inventory, or BREESI, can also be used by researchers and patient groups, and for epidemiological studies in exposed populations.
Sept. 16 in the journal PLOS ONE, the researchers reported that the BREESI accurately predicts scores on a comprehensive 50-question survey called the Quick Environmental Exposure and Sensitivity Inventory (QEESI). The QEESI, which the UT Health San Antonio group introduced online in 2014, is available at no charge to patients and clinicians.
Company highlights key factors expected to impact Q4 COVID-19 testing during UBS analyst event
COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as students go back to school and flu season hits its peak. XIFIN CEO Lâle White and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services, recently joined healthcare analysts from UBS for an audio conference to discuss the key factors that will impact COVID testing volumes heading into the fall, analyze activity across its customer lab networks, and provide an update on payor reimbursement activity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200922005762/en/
(Graphic: Business Wire)
“Six months into the COVID-19 pandemic, diagnostic labs nationwide continue to see high testing volumes. Early implementation of rapid diagnostics testing could positively impact overall testing